Eva Medtec is raising funds on Andes Capital. The company has developed an at-home automated lymphatic therapy system, Neuroglide. Eva Medtec’s Neuroglide is an over-the-counter, FDA-cleared medical device that is engineered to automate and emulate manual lymphatic drainage (MLD) therapy. It uses a calibrated pressure profile to remove cellular waste associated with inflammatory circulatory conditions, increase lymph flow, reduce pain significantly, promote relaxation and sleep, and improve life quality. Irene Anne Waldridge founded Eva Medtec in July 2016. The current crowdfunding campaign has a minimum and maximum target of $618,000. The campaign proceeds will be used for marketing, office and warehouse lease, regulatory and legal fees, equipment, supplies, research and development, IT and software, travel, liability insurance, and personnel expenses.
Investment Overview
Raised: $0
Deal Terms
Total Commitments ($USD)
- Platform
- Andes Capital
- Start Date
- 11/26/2024
- Close Date
- 11/19/2025
$618,000
$618,000
$300
Equity - Common
RegCF
$3.00
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Bloomington, Minnesota
- Company Website
-
Visit Website
Team
- Employees
- 4
Financials
-
Revenue
- $70,302
- Monthly Burn
- $22,569
-
Runway
- 0.3 months
- Gross Margin
- 60%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 11/19/2025 | Andes Capital | - | $0 | Equity - Common | Active | RegCF |
| 06/30/2023 | Netcapital | $8,997,823 | $0 | Equity - Common | Not Funded | RegCF |
| 03/20/2023 | StartEngine | $11,030,000 | $130,534 | Equity - Common | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.